Masahide Harada

Has grant

Associate Professor

Fujita Health University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Masahide Harada is an Associate Professor at Fujita Health University in Japan. His research primarily focuses on cardiovascular health, atrial fibrillation, and the impact of chronic kidney disease on clinical outcomes. Recent articles highlight his investigations into the influence of various ablation techniques and anticoagulation therapies on patient outcomes and biomarkers associated with atrial fibrillation.

Recent Grants

Grant: Close

Intracardiac/extracardiac circulating microRNA profiling in atrial fibrillation -cardiac specific biomarkers for atrial remodeling-

Open Date: 2016-04-01

Close Date: 2019-03-01

Articles (10)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Kunihiro Tsuchida

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Masahide Harada

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Influence of Worsening Renal Function and Baseline Chronic Kidney Disease on Clinical Outcomes in Patients With Chronic Coronary Syndromes: Insights From the REAL‐CAD Study

Impact of different energy sources on coagulation biomarkers and silent cerebral events in balloon-based ablation for atrial fibrillation

Effect of pulmonary vein isolation on rotor/multiple wavelet dynamics in persistent atrial fibrillation, association with vagal response and implications for adjunctive ablation

Circulating miR-20b-5p and miR-330-3p are novel biomarkers for progression of atrial fibrillation: Intracardiac/extracardiac plasma sample analysis by small RNA sequencing

Selvester QRS score predicts improvement of LVEF in atrial fibrillation patients with systolic heart failure

Cover Image, Volume 32, Issue 6

Wall thickness‐based adjustment of ablation index improves efficacy of pulmonary vein isolation in atrial fibrillation: Real‐time assessment by intracardiac echocardiography

Factors associated with silent cerebral events during atrial fibrillation ablation in patients on uninterrupted oral anticoagulation

Comparison of effectiveness and safety between uninterrupted direct oral anticoagulants with and without switching to dabigatran in atrial fibrillation ablation

Urinary Liver-Type Fatty-Acid-Binding Protein Predicts Long-Term Adverse Outcomes in Medical Cardiac Intensive Care Units

Collaborators (1)

Kunihiro Tsuchida

Make your next move.